TransAct Technologies Incorporated
US ˙ NasdaqGM ˙ US8929181035

Introduction

This page provides a comprehensive analysis of the known insider trading history of Management Corp Harbert. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Management Corp Harbert has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:TACT / TransAct Technologies Incorporated 10% Owner 640,168
US:QUMU / Qumu Corp Director 1,738,884
US:ENZ / Enzo Biochem, Inc. 10% Owner 5,175,913
10% Owner 0
US:STRM / Streamline Health Solutions, Inc. 10% Owner 6,683,274
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Management Corp Harbert. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases TACT / TransAct Technologies Incorporated - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in TACT / TransAct Technologies Incorporated. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TACT / TransAct Technologies Incorporated Insider Trades
Insider Sales TACT / TransAct Technologies Incorporated - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in TACT / TransAct Technologies Incorporated. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

TACT / TransAct Technologies Incorporated Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Management Corp Harbert as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2022-02-10 3 TACT TRANSACT TECHNOLOGIES INC
Common Stock, $0.01 par value
640,168
2021-08-13 2021-08-13 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 87,885 1,738,884 5.32 2.48 217,849 4,310,346
2021-08-13 2021-08-12 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 65,378 1,650,999 4.12 2.50 163,458 4,127,828
2021-08-13 2021-08-11 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 175,000 1,585,621 12.41 2.44 427,822 3,876,368
2021-03-17 2021-03-16 4 ENZ ENZO BIOCHEM INC
Common Stock
S - Sale -100,000 5,175,913 -1.90 4.54 -453,900 23,493,469
2021-03-17 2021-03-16 4 ENZ ENZO BIOCHEM INC
Common Stock
S - Sale -200,000 5,275,913 -3.65 4.70 -940,000 24,796,791
2021-03-17 2021-03-15 4 ENZ ENZO BIOCHEM INC
Common Stock
S - Sale -44,768 5,475,913 -0.81 5.00 -223,840 27,379,565
2021-03-17 2021-03-15 4 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value ("Common Stock")
S - Sale -100,000 5,520,681 -1.78 4.75 -475,000 26,223,235
2020-12-21 2020-12-21 4 PRCP PERCEPTRON INC/MI
Director Stock Option (Right to Buy)
D - Sale to Issuer -8,000 0 -100.00
2020-12-21 2020-12-21 4 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
D - Sale to Issuer -987,091 0 -100.00 7.00 -6,909,637
2020-12-21 2020-12-21 4 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
D - Sale to Issuer -34,086 0 -100.00 7.00 -238,602
2020-12-03 2020-12-01 4 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
A - Award 2,618 34,086 8.32 6.97 18,247 237,579
2020-09-03 2020-09-01 4 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
A - Award 4,284 31,468 15.76 4.26 18,250 134,054
2020-06-03 2020-06-01 4 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
A - Award 4,662 27,184 20.70 3.11 14,499 84,542
2020-03-04 2020-03-02 4 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
A - Award 3,172 22,522 16.39 4.57 14,496 102,926
2019-12-04 2019-12-02 4 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
A - Award 3,777 19,350 24.25 4.50 16,996 87,075
2019-11-12 2019-11-07 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 100,000 1,392,522 7.74 2.50 250,000 3,481,305
2019-10-18 3 STRM STREAMLINE HEALTH SOLUTIONS INC.
Common Stock, $0.01 par value
6,683,274
2019-10-18 3 STRM STREAMLINE HEALTH SOLUTIONS INC.
Common Stock, $0.01 par value
6,683,274
2019-10-18 3 STRM STREAMLINE HEALTH SOLUTIONS INC.
Common Stock, $0.01 par value
6,683,274
2019-10-18 3 STRM STREAMLINE HEALTH SOLUTIONS INC.
Common Stock, $0.01 par value
6,683,274
2019-10-18 3 STRM STREAMLINE HEALTH SOLUTIONS INC.
Common Stock, $0.01 par value
6,683,274
2019-10-18 3 STRM STREAMLINE HEALTH SOLUTIONS INC.
Common Stock, $0.01 par value
6,683,274
2019-10-18 3 STRM STREAMLINE HEALTH SOLUTIONS INC.
Common Stock, $0.01 par value
6,683,274
2019-10-18 3 STRM STREAMLINE HEALTH SOLUTIONS INC.
Common Stock, $0.01 par value
6,683,274
2019-10-18 3 STRM STREAMLINE HEALTH SOLUTIONS INC.
Common Stock, $0.01 par value
6,683,274
2019-09-05 2019-09-03 4 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
A - Award 3,222 15,573 26.09 4.50 14,499 70,078
2019-08-20 2019-08-20 4 ENZ ENZO BIOCHEM INC
Common Stock
P - Purchase 9,700 5,620,681 0.17 3.11 30,167 17,480,318
2019-08-20 2019-08-16 4 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value ("Common Stock")
P - Purchase 22,800 5,610,981 0.41 3.06 69,768 17,169,602
2019-07-24 2019-07-23 4 ENZ ENZO BIOCHEM INC
Common Stock
P - Purchase 409,200 5,588,181 7.90 3.65 1,493,580 20,396,861
2019-07-24 2019-07-22 4 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value ("Common Stock")
P - Purchase 9,644 5,178,981 0.19 3.64 35,104 18,851,491
2019-06-18 2019-06-14 4 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
A - Award 5,549 12,351 81.58 4.46 24,749 55,085
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,980,984
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,000,695
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,980,984
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,000,695
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,980,984
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,000,695
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,980,984
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,000,695
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,980,984
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,000,695
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,980,984
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,000,695
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,980,984
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,000,695
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,980,984
2019-06-14 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,000,695
2019-05-30 2019-05-30 4 ENZ ENZO BIOCHEM INC
Common Stock
P - Purchase 19,391 5,169,337 0.38 3.07 59,530 15,869,865
2019-05-30 2019-05-29 4 ENZ ENZO BIOCHEM INC
Common Stock
P - Purchase 19,050 5,149,946 0.37 3.08 58,674 15,861,834
2019-05-30 2019-05-28 4 ENZ ENZO BIOCHEM INC
Common Stock
P - Purchase 13,677 5,130,896 0.27 3.06 41,852 15,700,542
2019-05-30 2019-05-28 4 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value ("Common Stock")
P - Purchase 50,000 5,117,219 0.99 3.10 155,000 15,863,379
2019-05-22 2019-05-20 4 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value
P - Purchase 14,132 5,067,219 0.28 3.61 51,017 18,292,661
2019-05-22 3 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value
10,106,174
2019-05-22 3 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value
10,106,174
2019-05-22 3 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value
10,106,174
2019-05-22 3 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value
10,106,174
2019-05-22 3 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value
10,106,174
2019-05-22 3 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value
10,106,174
2019-05-22 3 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value
10,106,174
2019-05-22 3 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value
10,106,174
2019-05-22 3 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value
10,106,174
2019-05-22 3 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value
10,106,174
2019-05-22 3 ENZ ENZO BIOCHEM INC
Common Stock, $0.01 par value
10,106,174
2018-11-13 2018-11-09 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 38,265 1,267,522 3.11 2.54 97,243 3,221,154
2018-11-13 2018-11-08 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 8,928 1,229,257 0.73 2.44 21,750 2,994,593
2018-05-23 2018-05-21 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 20,000 1,220,329 1.67 2.39 47,862 2,920,369
2017-11-13 2017-11-13 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 87,300 1,200,329 7.84 2.46 215,133 2,957,971
2017-11-13 2017-11-10 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 6,850 1,113,029 0.62 2.45 16,782 2,726,921
2017-11-13 2017-11-09 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 9,300 1,106,179 0.85 2.44 22,731 2,703,723
2017-11-03 2017-11-03 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 37,919 1,096,879 3.58 2.39 90,721 2,624,283
2017-11-03 2017-11-02 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 67,172 1,058,960 6.77 2.45 164,558 2,594,240
2017-11-03 2017-11-01 4 QUMU Qumu Corp
Common Stock, $0.01 par value
P - Purchase 51,618 991,788 5.49 2.46 126,934 2,438,906
2017-11-03 3 QUMU Qumu Corp
Common Stock, $0.01 par value
1,880,340
2017-11-03 3 QUMU Qumu Corp
Common Stock, $0.01 par value
1,880,340
2017-11-03 3 QUMU Qumu Corp
Common Stock, $0.01 par value
1,880,340
2017-11-03 3 QUMU Qumu Corp
Common Stock, $0.01 par value
1,880,340
2017-11-03 3 QUMU Qumu Corp
Common Stock, $0.01 par value
1,880,340
2017-11-03 3 QUMU Qumu Corp
Common Stock, $0.01 par value
1,880,340
2017-11-03 3 QUMU Qumu Corp
Common Stock, $0.01 par value
1,880,340
2017-11-03 3 QUMU Qumu Corp
Common Stock, $0.01 par value
1,880,340
2016-07-05 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,008,200
2016-07-05 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,008,200
2016-07-05 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,008,200
2016-07-05 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,008,200
2016-07-05 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,008,200
2016-07-05 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,008,200
2016-07-05 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,008,200
2016-07-05 3 PRCP PERCEPTRON INC/MI
Common Stock, $0.01 par value
1,008,200
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)